What is the maximum daily dose of buspirone (Buspar) for an adult?

Maximum Daily Dose of Buspirone

The maximum recommended daily dose of buspirone is 60 mg per day, typically administered as 20 mg three times daily. 1, 2

Standard Dosing Guidelines

• Initial dose: Start at 5 mg twice daily (10 mg/day total) 1, 2
• Titration schedule: Increase gradually by 5 mg increments every 5-7 days based on clinical response and tolerability 2
• Maximum dose: 60 mg per day, divided as either 20 mg three times daily or 30 mg twice daily 1, 2
• Time to efficacy: Clinical response typically emerges within 2-4 weeks, though onset can range from 5-29 days 1, 2

Dosing Flexibility

While 60 mg/day is the standard maximum, doses up to 90 mg per day have been studied in clinical trials and found to be safe and well-tolerated. 2 The FDA label documents that clinical pharmacology trials administered doses as high as 375 mg/day to healthy volunteers, though this produced symptoms including nausea, vomiting, dizziness, drowsiness, miosis, and gastric distress. 3

Research studies support the safety of higher doses:

• A study in major depression used doses up to 90 mg/day with good tolerability 4
• Another depression trial employed a flexible dose schedule of 5-90 mg/day with a mean dose of 41-54 mg/day 5
• A case report documented successful use of 90 mg/day for aggressive behaviors in autism spectrum disorder 6

Special Population Considerations

Geriatric and frail patients: Initiate therapy at 2.5 mg twice daily (5 mg/day total) with gradual titration based on clinical response 2. Studies in elderly patients (≥65 years) using standard 15 mg/day dosing showed comparable efficacy and safety to younger adults, with a mean dose of 18 mg/day proving effective 7

Hepatic or renal impairment: Buspirone is metabolized by the liver and excreted by the kidneys. Patients with severe hepatic or renal impairment experience increased plasma levels and prolonged half-life; therefore, buspirone administration cannot be recommended in this population. 3

Clinical Pitfalls and Monitoring

• Discontinuation for lack of response: If a patient has not achieved therapeutic benefit after reaching the maintenance dose and allowing adequate time (2-4 weeks), consider alternative treatments rather than exceeding 60 mg/day in routine practice 1

• Drug interactions: Buspirone may interfere with urinary metanephrine/catecholamine assays, causing false-positive results for pheochromocytoma. Discontinue buspirone at least 48 hours before urine collection for catecholamines. 3

• Abuse potential: Recent pharmacovigilance data identified signals for "drug abuse" (n=43) and "intentional overdose" (n=30), indicating a potential risk of misuse during therapeutic use 8

• Serotonin syndrome risk: When combined with other serotonergic agents, buspirone can contribute to serotonin syndrome (n=83 reports in FAERS database) 8

Practical Dosing Algorithm

1. Start: 5 mg twice daily 1, 2
2. Week 1-2: Assess tolerability; if well-tolerated, increase to 7.5 mg twice daily
3. Week 2-3: Increase to 10 mg twice daily (20 mg/day total) 2
4. Week 3-4: Increase to 15 mg twice daily (30 mg/day total) if needed 2
5. Week 4-6: Increase to 20 mg three times daily (60 mg/day maximum) if needed 1, 2
6. Evaluate response: Allow 2-4 weeks at maintenance dose before judging efficacy 1, 2

For patients requiring doses above 60 mg/day: This exceeds standard recommendations but has been studied up to 90 mg/day in controlled trials with acceptable safety profiles. 2, 4, 5 Such dosing should be reserved for treatment-resistant cases under close monitoring, as the standard maximum remains 60 mg/day per guideline recommendations. 1, 2